Credit: Kenneth Zaret, PhD, Perelman School of Medicine, University of Pennsylvania
Scheme for generating induced pluripotent stem (iPS) cells from pancreatic cancer (PDAC) and using the PDAC-iPS cells to recapitulate cancer progression and early marker discovery.